The Board of Directors resolved to hold 2021 Annual General Meeting

1. Date of the board of directors resolution: Mar 12, 2021
2. Date for convening the shareholders’ meeting: Jun 21, 2021
3. Location for convening the shareholders’ meeting: Masterlink Securities Education and Training Center (11F., No.97, Sec. 2, Dunhua S. Rd., Da’ an Dist., Taipei City, Taiwan)
4. Cause or subjects for convening the meeting I, Report Items:

(1) 20120 Business Report
(2) 2020 Audit Committee’s Review Report
(3) Comprehensive business initiatives
(4) Amendment of company’s ‘Articles of Incorporation’
(5) Amendment of company’s ‘Ethical behavior standard for Board of directors and Managers’

5. Cause or subjects for convening the meeting II, Matters for Ratification:

(1) 2020 Settlement Statements
(2) 2020 Deficit Compensation

6. Cause or subjects for convening the meeting III, Matters for Discussion:

(1) Amendment of company’s ‘Articles of Incorporation’
(2) Amendment of company’s ‘Board of Directors Election Protocols’
(3) Amendment of ‘Transaction Operating Procedures for Stakeholders and Specific Companies and Groups’

7. Cause or subjects for convening the meeting IV, Elections:

(1) By-election of 6th Independent Director

8. Cause or subjects for convening the meeting V, Other Proposals:

(1) Remove the restriction of Competition Prohibition

9. Cause or subjects for convening the meeting VI, Extemporary Motions: None
10. Book closure starting date: Apr 23, 2021
11. Book closure ending date: Jun 21, 2021
12. TBD
13. TBD
14. Any other matters that need to be specified:

Pursuant to Article 172-1 of the Company Law, the Annual General Meeting will accept shareholders’ proposals from Apr 13, 2021 to Apr 23, 2021. Shareholders holding more than 1% of shares should deliver proposal with applicable contact information before 5:00pm on Apr 23, 2021 for the board of directors to review and respond (Please note the Annual General Meeting on the envelope and send it by priority mail). Overdue will not be accepted.
Proposal receiving office is the Financial Department of OBI Pharma Inc. (Address: 7th Floor, No. 369, Section 7, Zhongxiao East Road, Sedative Drugs, Taipei, Tel: 02-27866589, ext. 115/157). The shareholders will be able to exercise their voting rights electronically from May 22, 2021 to Jun 18, 2021. The electronic voting system is managed by Taiwan Depository and Clearing Corporation at
https://www.stockvote.com.tw